Reviews & Comparisons

At-Home Sleep Test vs. In-Lab Sleep Study: Which Do You Actually Need?

At-home sleep tests (HSAT) cost $150–$500 and accurately diagnose most obstructive sleep apnea cases. In-lab polysomnography catches central apnea, parasomnias, and narcolepsy that HSATs cannot. Here's how to choose.

By Dr. Marcus Bell·February 3, 2025·11 min read·Reviewed by Dr. Michael Torres, MD, Sleep Medicine

At-Home Sleep Test vs. In-Lab Sleep Study — Photograph for Sleep Editorial.

When a physician suspects sleep apnea, two diagnostic pathways exist: a home sleep apnea test (HSAT) that the patient administers themselves overnight, or an in-lab polysomnography (PSG) study conducted by trained technologists in a sleep center. The choice between them is not simply one of convenience versus thoroughness — it is a clinical decision that depends on what question the test needs to answer, the patient's health history, and which findings would change treatment.

Understanding the genuine differences between these two tests — what each measures, where each is reliable, and when each is appropriate — allows patients to advocate for the right test and interpret their results more accurately.

What a Home Sleep Apnea Test Measures

Home sleep apnea tests are portable, simplified devices that patients pick up from a physician's office, pharmacy, or a mail-delivery service, set up themselves before bed, wear overnight, and return for data download and interpretation. The most common type records three primary signals: nasal airflow (via a nasal cannula pressure transducer), respiratory effort (via a thoracic effort belt), and peripheral oxygen saturation (via a finger oximeter).

Some devices additionally record body position and heart rate. What none of the standard HSATs record is brain wave activity (EEG). This omission has a critical implication: because there is no EEG, the device cannot distinguish sleep from wakefulness. It calculates the Apnea-Hypopnea Index — the number of breathing disruption events per hour — by dividing total recorded events by total recording time, rather than by confirmed sleep time. This means the AHI from a home test is typically slightly lower than the AHI from a full PSG, because recording time includes minutes or hours when the patient may have been awake.

For people with moderate-to-severe obstructive sleep apnea, this underestimation is clinically tolerable — the degree of underestimation is not large enough to push a clearly positive result below the diagnostic threshold. For people with mild OSA, it may cause the HSAT to return a falsely normal or ambiguous result.

What In-Lab Polysomnography Measures

Polysomnography is the comprehensive standard. It records EEG (brain wave activity for sleep staging), electrooculography (eye movements for REM identification), electromyography (muscle activity in the chin and legs), electrocardiography (heart rhythm), respiratory effort belts, nasal and oral airflow sensors, pulse oximetry, and body position. Trained polysomnographic technologists monitor the data in real time throughout the night and can reapply sensors, adjust equipment, and respond to clinical events as they occur.

The resulting data allows the scoring sleep specialist to precisely characterize every 30-second epoch of the recording as a specific sleep stage, identify respiratory events precisely within sleep (not total recording time), document leg movements and their relationship to arousals, analyze heart rhythm, and identify complex sleep disorders that involve interactions between multiple physiological systems — none of which a home test can accomplish.

Diagnostic Accuracy: What the Research Shows

Multiple systematic reviews and meta-analyses have examined the diagnostic accuracy of HSATs relative to PSG as the reference standard. The general finding is that for adults with high pre-test probability of moderate-to-severe OSA and no significant comorbidities, HSATs demonstrate adequate sensitivity and specificity for the presence or absence of OSA. A meta-analysis in the American Journal of Respiratory and Critical Care Medicine found that Type III home sleep tests had a sensitivity of approximately 84 to 94 percent and specificity of 77 to 100 percent for OSA at a standard AHI threshold of 5 or more events per hour.

These numbers support HSAT use as a first-line test in appropriate clinical contexts. However, they also reflect that a meaningful proportion of people with OSA will receive a false-negative result on a home test, and that the accuracy degrades significantly in populations with lower pre-test probability, comorbid conditions, or suspected non-OSA sleep disorders.

Clinical Appropriateness: When Each Test Is the Right Choice

When a Home Sleep Test Is Appropriate

The American Academy of Sleep Medicine's clinical practice guidelines support HSAT use when the following conditions are met: the patient has a high clinical probability of moderate-to-severe OSA based on history and examination; there is no significant cardiorespiratory comorbidity (uncompensated heart failure, moderate-to-severe COPD, pulmonary hypertension, respiratory muscle weakness); there is no suspicion of another primary sleep disorder beyond OSA (such as narcolepsy, central sleep apnea, REM sleep behavior disorder, periodic limb movement disorder, or complex insomnia); and the patient can physically operate the device and attach the sensors correctly.

HSAT is also appropriate for monitoring treatment response in patients with confirmed OSA who are being evaluated during or after CPAP titration, where the clinical question is whether breathing has normalized rather than whether OSA is present.

When In-Lab Polysomnography Is Required

PSG is the required test when any of the following apply: suspicion of a sleep disorder other than or in addition to obstructive sleep apnea; a negative or inconclusive home sleep test in a patient with high clinical suspicion for OSA; significant cardiorespiratory comorbidity; neuromuscular disease; significant obesity hypoventilation syndrome; a previous failed or inconclusive HSAT; children (home tests are not validated for pediatric populations and PSG is required); or the presence of unusual or complex sleep complaints that require comprehensive evaluation. PSG is also standard for CPAP titration when performed in a clinical setting, for the diagnosis of narcolepsy (which requires a PSG followed by a multiple sleep latency test the next day), and for the evaluation of parasomnias.

Practical Differences: Cost, Access, and Comfort

Cost

Home sleep tests are considerably less expensive than in-lab PSG. An HSAT typically costs $150 to $500 out of pocket, and most insurance plans cover it as the preferred first-line diagnostic step for suspected OSA, often with no or minimal cost-sharing after deductible. In-lab PSG is typically billed at $1,500 to $5,000 and requires prior authorization in most insurance plans. Most insurers require a failed or inconclusive HSAT, or clinical documentation of why in-lab testing is medically necessary, before approving PSG.

Access and Wait Times

HSAT dramatically expands access to sleep apnea diagnosis. Mail-delivery HSAT services can provide a device within days, compared to wait times of weeks to months for in-lab PSG slots at many sleep centers. For patients in rural areas without nearby sleep laboratories, or for those whose work schedules or caregiving responsibilities make a full night away from home impractical, HSAT is often the only feasible option.

Patient Experience

Many patients prefer the home environment for sleep testing, reasoning that they will sleep more naturally in their own bed. This is partially true — the "first night effect" (reduced sleep quality in an unfamiliar environment) is a real phenomenon in PSG. However, HSATs carry their own reliability challenges: user error in sensor placement, device malfunctions, and sensors falling off during the night are more common than technical issues in monitored in-lab studies, and each of these can produce invalid or inconclusive results requiring repeat testing.

Interpreting Home Sleep Test Results

A home sleep test result requires careful interpretation in clinical context. A positive result (AHI ≥ 5 events per hour with symptoms) is generally reliable for confirming the presence of OSA in an appropriate patient. A negative result is less reliable — a negative HSAT in a patient with high clinical suspicion for OSA should prompt in-lab PSG rather than reassurance. An inconclusive result (due to poor data quality from sensor loss or recording failure) should prompt repeat testing, either at home or in the laboratory.

The AHI threshold for diagnosis and treatment is not uniform across all clinical guidelines: mild OSA is defined as AHI 5–14 per hour, moderate as 15–29, and severe as ≥30. Treatment decisions — particularly the decision to initiate CPAP therapy — take into account not only the AHI but also the degree of oxygen desaturation, the distribution of events across sleep positions, and the severity of daytime symptoms.

The Complementary Role of Both Tests

In modern clinical practice, HSAT and PSG are frequently used sequentially rather than as alternatives. The diagnostic pathway for most patients with suspected OSA now begins with an HSAT; if positive, CPAP titration may follow (either in a lab or through an auto-titrating CPAP device at home). If the HSAT is negative or inconclusive in a high-suspicion patient, PSG provides the definitive evaluation. This stepped approach balances cost efficiency and access against the comprehensive evaluation that complex cases require.

Understanding where you fit in this diagnostic pathway — and advocating for the appropriate test given your clinical history — is an important component of navigating the sleep medicine system effectively.

Frequently Asked Questions

Can a home sleep test diagnose sleep apnea definitively?

A positive home sleep test is generally sufficient to confirm moderate-to-severe OSA in adults with a high clinical pretest probability and no significant comorbidities. A negative home test in someone with strong symptoms is not definitive — in-lab polysomnography is needed to rule out OSA reliably in that scenario.

What should I do if my home sleep test result is negative but I still feel unrefreshed?

Ask your physician for an in-lab polysomnography study. A negative HSAT in someone with persistent daytime sleepiness and unrefreshing sleep may reflect a false-negative result (particularly if the AHI is borderline), a non-OSA sleep disorder such as PLMD, upper airway resistance syndrome, or narcolepsy, none of which are diagnosed by standard home testing.

Do I need a referral to get a home sleep test?

In most cases, yes. A physician order is required for a home sleep apnea test to be covered by insurance. Some direct-to-consumer services offer HSATs without a prescription, but these are not typically covered by insurance and results may not be interpreted by a sleep medicine physician. A physician referral ensures appropriate clinical interpretation and a clear pathway to treatment if OSA is confirmed.

How accurate are home sleep tests for mild sleep apnea?

Less accurate than for moderate-to-severe OSA. The absence of EEG means the AHI is calculated on recording time rather than confirmed sleep time, which tends to underestimate event frequency. For borderline or mild cases, the sensitivity of home testing is lower, and a negative result is less reassuring. In-lab PSG is preferable when mild OSA is clinically suspected and treatment decisions depend on an accurate severity assessment.

The Takeaway

Understanding the evidence and mechanisms behind effective insomnia treatment empowers people to make better decisions about their own care. The research is clear that behavioral treatment — specifically CBT-I — produces the most durable improvements in sleep outcomes for chronic insomnia, with a safety profile that pharmacological treatments cannot match. Accessing this treatment through in-person specialists, telehealth, or digital programs has never been more achievable. The most important next step is matching the treatment approach to the specific mechanisms driving the sleep problem — and then following through with the behavioral work that produces lasting change.

Whether you are at the beginning of investigating a sleep problem, midway through a treatment course, or managing long-standing insomnia that has resisted prior interventions, the core message of the evidence is consistent: the brain's capacity for restorative sleep is intact in most people with insomnia. What behavioral treatment does is remove the patterns that are blocking it — not create a new capacity, but restore one that was present all along. That restoration, for most people who complete a full course of evidence-based treatment, is achievable within weeks.

Disclosure

Sleep Editorial is an independent publication. This article was reported and written without compensation from any product or service mentioned. Sleep Editorial does not provide medical advice; consult a qualified clinician for diagnosis and treatment.